men and women, age 70 to 79 years, were studied. In the Stockholm County cohort, only white men, age 62 to 64 years, were studied. The association between the metabolic syndrome and a higher prevalence of elevated levels of circulating oxidized LDL in the Health ABC cohort was independent of age, gender, and ethnicity. Although the Health ABC cohort was older, with a restricted age range, this suggests that the contrasting data are not likely to be attributable to differences in age, gender, and ethnicity.
In Response:
We read with interest the letter written by Holvoet and colleagues referring to our article published recently in Arteriosclerosis, Thrombosis, and Vascular Biology. 1 Holvoet et al discuss reasons for our failure to find increased concentrations of circulating oxidized LDL (oxLDL) in subjects with the metabolic syndrome, a relationship that they 2 and others 3 have reported previously.
Their first point relates to the use of different definitions of the metabolic syndrome. This point is discussed in our article.
Their second point relates to subject recruitment. They suggest that our stringent exclusion criteria (eg, exclusion of subjects with diabetes mellitus, antihypertensive drug treatment, or a BMI Ͼ35 kg/m 2 ) could have affected the relationship between the metabolic syndrome and circulating oxLDL concentrations. Because the characteristics of our cohort are very similar to those of Sigurdardottir et al, 3 a cohort in which higher oxLDL concentrations were associated with the metabolic syndrome, we think that this explanation is unlikely. This point is discussed in our article.
Their third suggestion is that small sample size limited our statistical power. This point is discussed in our article.
Their fourth suggestion is that there are fundamental metabolic differences between populations, possibly caused by differences in genetic architecture. However, they say that this seems unlikely. We agree, especially because Sigurdardottir et al 3 investigated subjects with an almost identical genetic background (healthy men with Swedish ancestry) to those in our study.
Their final point relates to our failure to adjust oxLDL for LDL-cholesterol concentrations. In our cohort oxLDL concentra-
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Letter to the Editor tions adjusted for LDL-cholesterol were not elevated in the metabolic syndrome.
Thus we thank Holvoet et al for their comments on our study, but consider that to a great extent we had addressed their points in our article. 
Per Sjogren Anders Hamsten

